Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Merck Millipore Live Lab Tour 2012 to Visit Science Zones in Europe

Published: Monday, April 23, 2012
Last Updated: Monday, April 23, 2012
Bookmark and Share
The “Live Lab Tour” will be ready to roll on 15 May. This innovative concept brings latest Merck Millipore technologies to the workplace, with one-to-one planned meetings available at each site.

Merck Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany has announced the schedule for the Merck Millipore Live Lab Tour 2012 that will visit nine science parks and institutions in Europe starting in May.

The “Live Lab,” a 60-square-meter exhibition space housed in an eye-catching coach-style vehicle, is aLLT-visual-(3).gif novel way to bring information about new technologies right to the workplace. Keltoum Benchikh, Lab Water Head of Global Marketing-Communications, explains that the Live Lab Tour concept is part of a portfolio of marketing communications tools designed to present product information in the easiest, most accessible manner possible. “Live Lab visitors will discover our product offering in situ, and will get actual hands-on experience working with Merck Millipore equipment and other materials,” she says. “In addition, Merck Millipore experts will be present at each site to discuss best practices that will help visitors optimize protocols and improve their laboratory work flows,” she adds.

Three laboratories will be set up within the vehicle: a pharmaceutical lab, an academic research lab, and a food and beverages lab. All will be equipped with the Merck Millipore solutions required to perform actual experiments.

For visitors who would like to discuss their specific situations in more detail, special one-to-one sessions with Merck Millipore experts are available at each site from 10:00 am to 3:30 pm every day.

Schedule: Merck Millipore Live Lab Tour 2012
UK – London: 15 May, University College London
UK – London: 16 May, Imperial College
UK – Oxford: 17 May, Milton Science Park
UK – Newcastle: 21 May, Centre for Life
NL – Utrecht: 24 May, Universiteit Utrecht
BE – Liège: 29 May, Université de Liège
FR – Molsheim: 31 May, Merck Millipore
IT – Milan: 5 June, INFN (Italian National Institute of Nuclear Physics)

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore Announces Incoming CEO and President
Udit Batra, Ph.D. will be responsible for the organization’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations.
Tuesday, April 15, 2014
Merck KGaA Passes EXCiPACT Audit for Certification as Provider of Pharmaceutical Excipients
Ensures current GMP and GDP requirements applied to pharmaceutical excipients through a recognized auditing and certification process.
Friday, August 02, 2013
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Nanomedicine for Breast Cancer Treatment
Using nanoparticles measuring only billionths of a meter in size, doctors are able to deliver drug molecules directly to the affected tissue.
Clamping Down on Biomolecules
Physicists have developed a novel nanotool that provides a means of characterizing the mechanical properties of biomolecules.
Smartphone Laboratory Detects Cancer
Researchers develop low-cost, portable laboratory on a smartphonecapable of analysing multiple samples simultaneously.
MRIs for Fetal Health
Algorithm could help analyze fetal scans to determine whether interventions are warranted.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Transgenomic, Precipio Diagnostics Merger
Merger will creates a robust diagnostic platform focused on improving accuracy of cancer diagnoses.
Inflammation Test May Predict Cardiovascular Disease
An assessment combining measures of immune-cell responsiveness predicted cardiovascular problems in individuals who likely would have slipped under the radar.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos